What is the stroke risk reduction associated with carotid endarterectomy in patients with symptomatic carotid disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Stroke Risk Reduction After Carotid Endarterectomy for Symptomatic Disease

Carotid endarterectomy reduces the 5-year absolute stroke risk by 16% in patients with 70-99% symptomatic carotid stenosis, translating to a number needed to treat of 6 to prevent one stroke. 1

Magnitude of Benefit by Stenosis Severity

The stroke risk reduction from carotid endarterectomy varies substantially based on the degree of stenosis:

Severe Stenosis (70-99%)

  • Absolute risk reduction: 16.0% at 5 years (from 26% to 9%) 1, 2
  • Relative risk reduction: 53% 1
  • Number needed to treat: 6 1
  • This represents the strongest evidence for benefit, with highly significant results (p < 0.001) 3

Moderate Stenosis (50-69%)

  • Absolute risk reduction: 4.6% at 5 years (from 22.2% to 15.7%) 1, 2, 4
  • Relative risk reduction: 23% 2
  • Number needed to treat: 22 1
  • The benefit is substantially smaller and requires exceptional surgical skill 4

Mild Stenosis (<50%)

  • No significant benefit demonstrated 5, 2
  • Surgery is not recommended for this group 1, 6

Critical Context: Perioperative Risk

These benefits assume a combined perioperative stroke and death rate of 6-7%, which was the rate achieved in the landmark randomized trials 1. The net benefit of surgery depends entirely on keeping complications below this threshold:

  • For symptomatic patients with severe stenosis, surgery remains beneficial even with 6-7% perioperative risk
  • For moderate stenosis (50-69%), the surgeon/center must demonstrate <6% perioperative morbidity and mortality for any benefit to accrue 7
  • The smaller absolute benefit in moderate stenosis means complications quickly eliminate any advantage

Timing Matters Significantly

Surgery should be performed within 14 days of the ischemic event 1, 7, with benefit greatest when performed within the first few days 1. Pooled analyses show:

  • Greatest benefit occurs when surgery is performed within 2 weeks of symptoms 5, 2
  • Benefit falls rapidly with increasing delay 5
  • Patients randomized within 2 weeks had substantially better outcomes than those treated later 1

Patient Factors That Modify Benefit

The absolute risk reduction is greatest in specific subgroups 1, 5, 4:

  • Men benefit more than women (though women still benefit from surgery for severe stenosis)
  • Age ≥75 years shows greater absolute benefit 1
  • Recent stroke (rather than TIA) as the qualifying event predicts better outcomes 4
  • Hemispheric symptoms (rather than retinal symptoms alone) indicate higher benefit 4

Long-Term Durability

The benefit of carotid endarterectomy is durable over 8 years in patients with severe stenosis 4. The 30-day rate of death or disabling stroke was only 2.1%, increasing to just 6.7% at 8 years, demonstrating excellent long-term stroke prevention 4.

Common Pitfalls to Avoid

  1. Do not offer surgery for <50% stenosis - no benefit has been demonstrated 1, 5, 6

  2. Do not proceed if your center's perioperative complication rate exceeds 6% - this eliminates the benefit, particularly for moderate stenosis 1

  3. Do not delay surgery beyond 14 days in neurologically stable patients - benefit decreases with time 1, 7

  4. Do not ignore stenosis measurement method - ensure stenosis is measured by CTA using NASCET criteria, as different measurement methods yield different stenosis percentages 1

  5. For moderate stenosis (50-69%), carefully select patients - consider age, sex, symptom type, and comorbidities, as the absolute benefit is modest 5, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.